Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Ovation Science ( (TSE:OVAT) ) is now available.
Ovation Science Inc. has granted 2.2 million stock options to its directors and officers, exercisable at $0.05 per share for two years from the grant date. The move strengthens equity-based incentives for the company’s leadership, potentially aligning management interests more closely with shareholders as Ovation advances commercialization of its patented Invisicare-based cannabinoid and skincare product portfolio in the wellness and beauty markets.
The most recent analyst rating on (TSE:OVAT) stock is a Hold with a C$0.04 price target. To see the full list of analyst forecasts on Ovation Science stock, see the TSE:OVAT Stock Forecast page.
Spark’s Take on TSE:OVAT Stock
According to Spark, TipRanks’ AI Analyst, TSE:OVAT is a Neutral.
The score is primarily constrained by weak financial performance (ongoing losses, negative equity, and cash burn). Technical indicators add modest pressure with negative MACD and sub-50 RSI, while valuation remains unattractive due to loss-making status and no dividend support.
To see Spark’s full report on TSE:OVAT stock, click here.
More about Ovation Science
Ovation Science Inc. is a research and development company focused on topical and transdermal consumer products, including CBD/THC and other cannabinoid-based formulations. These products are commercialized through licensing agreements and under Ovation’s own brands, ARLO CBD Beauty and InVibe MD, all built on its patented Invisicare skin delivery technology, which enhances ingredient absorption and is protected by patents and proprietary formulations. With more than two decades of experience in topical and transdermal drug delivery, Ovation has developed a pipeline of over thirty proprietary medical, wellness, and anti-aging/beauty products, generating revenue from royalties, Invisicare sales and its own product sales, with operations in Vancouver and Las Vegas.
Average Trading Volume: 39,792
Technical Sentiment Signal: Sell
Current Market Cap: C$1.41M
For detailed information about OVAT stock, go to TipRanks’ Stock Analysis page.